Increased carbamazepine-related SJS/TEN risk with HLA-B*1502

By  

Reactions Weekly, Vol. 1, Iss. 1183, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Carbamazepine, HLA-B*1502 and risk of Stevens––Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

By Ferrell P Brent   McLeod Howard L  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1543-1546

Future Medicine

Access to resources Recommend Favorite

External quality assessment for laboratory testing of HLA‐B*15:02 allele in relation to carbamazepine therapy

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

By Alfirevic Ana   Jorgensen Andrea L   Williamson Paula R   Chadwick David W   Park B Kevin   Pirmohamed Munir  

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 813-818

Future Medicine

Access to resources Recommend Favorite

HLA-B*1502 Allele is Associated with a Cross-reactivity Pattern of Cutaneous Adverse Reactions to Antiepileptic Drugs

By Wang J   Zhang J   Wu X   Yu P   Hong Z  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 377-382

Field House Publishing

Access to resources Recommend Favorite